24/05/2024  07:57:06 Chg. -0.2000 Volume Bid21:59:57 Ask21:59:57 Market Capitalization Dividend Y. P/E Ratio
22.0000EUR -0.90% -
Turnover: -
20.6000Bid Size: 200 22.4000Ask Size: 200 1.43 bill.EUR - -

Business description

Genus is a world-leading animal genetics company. It provides farmers with superior genetics that enable them to more efficiently produce higher-quality animal protein, in the form of meat and milk. Genus is the market leader in porcine, dairy and beef genetics and is uniquely positioned as a global player, with a dedicated, multi-species research and development (‘R&D’) function and an international distribution network.
 

Management board & Supervisory board

CEO
Jorgen Kokke
Management board
Alison Henriksen, Dan Hartley, Dr. Nate Zwald, Jerry Thompson, Angelle Rosata, Dr Elena Rice, Dr Matt Culbertson
Supervisory board
Iain Ferguson, Jorgen Kokke, Alison Henriksen, Lysanne Gray, Lesley Knox, Jason Chin, Dan Hartley
 

Company data

Name: Genus plc
Address: Matrix House, Basing View,UK-Basingstoke RG21 4DZ, Hampshire
Phone: +44-1256-347100
Fax: +44-1256-477385
E-mail: -
Internet: www.genusplc.com/
Industry: Biotechnology
Sector: Biotechnology
Sub sector: Biotechnology
End of financial year: 30/06
Free Float: -
IPO date: -

Investor relations

Name: Anand Date
IR phone: +44-7815-676-011
IR Fax: -
IR e-mail: anand.date@genusplc.com

Company calendar

CW 36 | 05/09/2024 4th Quarter/Annual Report
CW 47 | 20/11/2024 General Shareholder Meeting
 

Main Shareholders

Others
 
55.56%
Baillie Gifford
 
8.54%
Abrdn
 
6.24%
Wellington Management
 
5.77%
Columbia Threadneedle Investments
 
5.68%
BlackRock
 
5.30%
Vanguard Group
 
4.69%
Devon Equity Management
 
4.41%
Capital Group
 
3.81%